» Articles » PMID: 27753008

Neurotoxicology of Synthetic Cathinone Analogs

Overview
Publisher Springer
Specialty Psychology
Date 2016 Oct 19
PMID 27753008
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The present review briefly explores the neurotoxic properties of methcathinone, mephedrone, methylone, and methylenedioxypyrovalerone (MDPV), four synthetic cathinones most commonly found in "bath salts." Cathinones are β-keto analogs of the commonly abused amphetamines and display pharmacological effects resembling cocaine and amphetamines, but despite their commonalities in chemical structures, synthetic cathinones possess distinct neuropharmacological profiles and produce unique effects. Among the similarities of synthetic cathinones with their non-keto analogs are their targeting of monoamine systems, the release of neurotransmitters, and their stimulant properties. Most of the literature on synthetic cathinones has focused on describing their properties as psychostimulants, their behavioral effects on locomotion, memory, and potential for abuse, whereas descriptions of their neurotoxic properties are not abundant. The biochemical gauges of neurotoxicity induced by non-keto analogs are well studied in humans and experimental animals and include their ability to induce neuroinflammation, oxidative stress, excitotoxicity, temperature alterations as well as dysregulation of neurotransmitter systems and induce changes in monoamine transporters and receptors. These neurotoxicity gauges will serve as parameters to discuss the effects of the four previously mentioned synthetic cathinones alone or in combination with either another cathinone or with some of their non-keto analogs. Bath salts are not a defined combination of drugs and may consist of one synthetic cathinone compound or combinations of more cathinones. Furthermore, this review also presents some of the mechanisms that are thought to underlie this toxicity. A better understanding of the cellular and molecular mechanisms involved in the synthetic cathinones-induced neurotoxicity should contribute to generate modern therapeutic approaches to prevent or attenuate the adverse consequences of use of these drugs in humans.

Citing Articles

Clinical and Public Health Challenge of Handling Synthetic Cathinone and Cannabinoid Abuse in Pediatric Care: A Narrative Review.

Ricci V, Maina G Pediatr Rep. 2025; 17(1).

PMID: 39997626 PMC: 11857941. DOI: 10.3390/pediatric17010019.


Structure-Activity Relationship of Synthetic Cathinones: An Updated Review.

Nadal-Gratacos N, Pazos M, Pubill D, Camarasa J, Escubedo E, Berzosa X ACS Pharmacol Transl Sci. 2024; 7(9):2588-2603.

PMID: 39296271 PMC: 11406692. DOI: 10.1021/acsptsci.4c00299.


Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective.

Chen S, Zhou W, Lai M Brain Sci. 2024; 14(4).

PMID: 38671986 PMC: 11048581. DOI: 10.3390/brainsci14040334.


Effects of Prenatal Methcathinone Exposure on the Neurological Behavior of Adult Offspring.

Youyou Z, Zhaoyang L, Chen L, Shuquan Z, Hui W Curr Neuropharmacol. 2024; 22(13):2256-2262.

PMID: 38333971 PMC: 11337688. DOI: 10.2174/1570159X22666240128004722.


Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones.

Fitzgerald L, Gannon B, Walther D, Landavazo A, Hiranita T, Blough B Neuropharmacology. 2023; 245:109827.

PMID: 38154512 PMC: 10842458. DOI: 10.1016/j.neuropharm.2023.109827.


References
1.
Yamamoto B, Moszczynska A, Gudelsky G . Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci. 2010; 1187:101-21. PMC: 3955986. DOI: 10.1111/j.1749-6632.2009.05141.x. View

2.
Thomas D, Walker P, Benjamins J, Geddes T, Kuhn D . Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther. 2004; 311(1):1-7. DOI: 10.1124/jpet.104.070961. View

3.
Thomas D, Dowgiert J, Geddes T, Francescutti-Verbeem D, Liu X, Kuhn D . Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett. 2004; 367(3):349-54. DOI: 10.1016/j.neulet.2004.06.065. View

4.
Rubio-Araiz A, Perez-Hernandez M, Urrutia A, Porcu F, Borcel E, Gutierrez-Lopez M . 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. Int J Neuropsychopharmacol. 2014; 17(8):1243-55. DOI: 10.1017/S1461145714000145. View

5.
Rockhold R, Carlton Jr F, Corkern R, DeRouen L, Bennett J, HUME A . Methcathinone intoxication in the rat: abrogation by dextrorphan. Ann Emerg Med. 1997; 29(3):383-91. DOI: 10.1016/s0196-0644(97)70351-2. View